Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia
作者： Anand Mattai , Alex Chavez , Deanna Greenstein , Liv Clasen , Jennifer Bakalar
DOI: 10.1016/J.SCHRES.2009.10.018
关键词:
摘要: Background: Little is known about the effects of antipsychotic medications on gray matter (GM) in schizophrenia. Although clozapine remains most effective medication treatment-refractory cases, it unknown whether has a differential effect GM development.
elsevier.com
schres-journal.com 参考文章(47)
Nitin Gogtay, Anna Ordonez, David H. Herman, Kiralee M. Hayashi, Deanna Greenstein, Cathy Vaituzis, Marge Lenane, Liv Clasen, Wendy Sharp, Jay N. Giedd, David Jung, Tom F. Nugent III, Arthur W. Toga, Ellen Leibenluft, Paul M. Thompson, Judith L. Rapoport, Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. Journal of Child Psychology and Psychiatry. ,vol. 48, pp. 852- 862 ,(2007) , 10.1111/J.1469-7610.2007.01747.X
N. Gogtay, Cortical Brain Development in Schizophrenia: Insights From Neuroimaging Studies in Childhood-Onset Schizophrenia Schizophrenia Bulletin. ,vol. 34, pp. 30- 36 ,(2007) , 10.1093/SCHBUL/SBM103
Babak Khorram, Donna J. Lang, Lili C. Kopala, Robert A. Vandorpe, Qing Rui, Vina M. Goghari, Geoffrey N. Smith, William G. Honer, Reduced Thalamic Volume in Patients With Chronic Schizophrenia After Switching From Typical Antipsychotic Medications to Olanzapine American Journal of Psychiatry. ,vol. 163, pp. 2005- 2007 ,(2006) , 10.1176/AJP.2006.163.11.2005
J.G. Sled, A.P. Zijdenbos, A.C. Evans, A nonparametric method for automatic correction of intensity nonuniformity in MRI data IEEE Transactions on Medical Imaging. ,vol. 17, pp. 87- 97 ,(1998) , 10.1109/42.668698
Jeffrey A. Lieberman, T. Scott Stroup, Joseph P. McEvoy, Marvin S. Swartz, Robert A. Rosenheck, Diana O. Perkins, Richard S.E. Keefe, Sonia M. Davis, Clarence E. Davis, Barry D. Lebowitz, Joanne Severe, John K. Hsiao, Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia The New England Journal of Medicine. ,vol. 353, pp. 1209- 1223 ,(2005) , 10.1056/NEJMOA051688
A.P. Zijdenbos, R. Forghani, A.C. Evans, Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis IEEE Transactions on Medical Imaging. ,vol. 21, pp. 1280- 1291 ,(2002) , 10.1109/TMI.2002.806283
Christopher R. Genovese, Nicole A. Lazar, Thomas Nichols, Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage. ,vol. 15, pp. 870- 878 ,(2002) , 10.1006/NIMG.2001.1037
Nitin Gogtay, Alexandra Sporn, Liv S. Clasen, Tom F. Nugent, Deanna Greenstein, Rob Nicolson, Jay N. Giedd, Marge Lenane, Pete Gochman, Alan Evans, Judith L. Rapoport, Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Archives of General Psychiatry. ,vol. 61, pp. 17- 22 ,(2004) , 10.1001/ARCHPSYC.61.1.17
Richard S.E. Keefe, Joanne Severe, John K. Hsiao, Joseph Patrick McEvoy, Sonia M. Davis, Robert A. Rosenheck, Herbert Y. Meltzer, Diana O. Perkins, Marvin S. Swartz, Jeffrey A. Lieberman, T. Scott Stroup, Clarence E. Davis, Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment American Journal of Psychiatry. ,vol. 163, pp. 600- 610 ,(2006) , 10.1176/APPI.AJP.163.4.600
John M. Kane, Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. British Journal of Psychiatry. ,vol. 160, pp. 41- 45 ,(1992) , 10.1192/S0007125000296918